American Express Company logo AXP - American Express Company

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 22
HOLD 31
SELL 4
STRONG
SELL
0
| PRICE TARGET: $381.83 DETAILS
HIGH: $415.00
LOW: $324.00
MEDIAN: $387.50
CONSENSUS: $381.83
UPSIDE: 8.91%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 80% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 19.3% above fair value
Current Price $350.58
Bear Case $205.76 41.3% downside ($205.76 - $350.58) / $350.58 = -41.3% ROTCE 20.0% → 2.65x TBV
Fair Value $293.94 16.2% downside ($293.94 - $350.58) / $350.58 = -16.2% ROTCE 25.0% → 4.00x TBV
Bull Case $382.13 9.0% upside ($382.13 - $350.58) / $350.58 = 9.0% ROTCE 30.0% → 4.00x TBV

Adjust Assumptions

38.0%
10.0%

Key Value Driver

ROTCE (38.0%) vs. cost of equity (10.0%)

Implied Market Multiple 8.39x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $381.83 from 57 analysts, using a 35% weight on analyst consensus. That produces an estimated intrinsic value of $293.94 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $381.83 (from 57 analysts). Our estimate is 35% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly